Images Powered by Shutterstock
A Patient's Story:

A Patient's Story:

by Bryce Olson   |   September 19, 2022 A Patient’s Story: “When Too Much of a Bad Thing Can Be Good!” My name is Bryce Olson. I’ve been battling aggressive stage IV metastatic...

About Prostate Cancer

About Prostate Cancer

What exactly is prostate cancer? When cells in the prostate multiply too quickly and grow out of control, this creates a cancerous tumour. Often, this type of cancer grows...

Representative La Shawn K. Ford to be Honored as 2022 ZERO Health Equity Advocacy Award Recipient | ZERO - The End of Prostate Cancer

Representative La Shawn K. Ford to be Honored as 2022 ZERO Health Equity Advocacy Award Recipient | ZERO - The End of Prostate Cancer

Representative La Shawn K. Ford to be Honored as 2022 ZERO Health Equity Advocacy Award Recipient Rep. Ford to be recognized for advocacy of lifesaving bill to increase access...

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer Estefania Labanca Affiliations Department of Genitourinary Medical Oncology, The...

High Efficiency Capture of Biomarker miRNA15a for Noninvasive Diagnosis of Malignant Kidney Tumors

High Efficiency Capture of Biomarker miRNA15a for Noninvasive Diagnosis of Malignant Kidney Tumors

High Efficiency Capture of Biomarker miRNA15a for Noninvasive Diagnosis of Malignant Kidney Tumors - Beyond the Abstract May 19, 2022 miRNA15a – beyond being just a diagnostic...

A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer

A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer

Prostate cancer is the most heritable cancer. There is a need to identify possible modifiable factors for men at an increased risk of prostate cancer due to genetic factors. To...

Metastases Directed Therapy and Radiation in Oligometastatic Disease Patients - Robson Ferrigno

Metastases Directed Therapy and Radiation in Oligometastatic Disease Patients - Robson Ferrigno

Robson Ferrigno joins Phillip Koo at the 13th International Uro-Oncology Congress in São Paulo, Brazil in a discussion on salvage treatment after radiation failure and the...

 The Standard of Care for Low Risk Prostate Cancer

The Standard of Care for Low Risk Prostate Cancer

This change is timely, and particularly notable in contrast to the NCCN guideline, which last year not only reiterated the “very low risk” category but transiently removed...

Dosimetric Impact of Interfraction Prostate and Seminal Vesicle Volume Changes and Rotation: A Post-Hoc Analysis of a Phase III Randomized Trial of MRI-Guided Versus CT-Guided Stereotactic Body Radiotherapy

Dosimetric Impact of Interfraction Prostate and Seminal Vesicle Volume Changes and Rotation: A Post-Hoc Analysis of a Phase III Randomized Trial of MRI-Guided Versus CT-Guided Stereotactic Body Radiotherapy

Prostate Cancer SHARE Dosimetric Impact of Interfraction Prostate and Seminal Vesicle Volume Changes and Rotation: A Post-Hoc Analysis of a Phase III Randomized Trial of...

 Urinary Function Following High Dose Intensity Modulated Radiotherapy for Clinically Localized Prostate Cancer

Urinary Function Following High Dose Intensity Modulated Radiotherapy for Clinically Localized Prostate Cancer

(UroToday.com) Shannon McNall and team presented a thought-provoking study that investigated prostate cancer treatment. External beam radiotherapy (EBRT) is a common treatment...

 Best Prostate Biopsy Techniques in 2022

Best Prostate Biopsy Techniques in 2022

(UroToday.com) The 2022 Annual Meeting of the American Urological Association was host to a panel discussion of the best prostate biopsy techniques in 2022. This session was...

Bayer to Present Key Data Across Oncology Portfolio Showcasing Significant Advances in Cancer Care at 2022 ASCO Annual Meeting

Bayer to Present Key Data Across Oncology Portfolio Showcasing Significant Advances in Cancer Care at 2022 ASCO Annual Meeting

ASCO 2022 Press Releases SHARE Bayer to Present Key Data Across Oncology Portfolio Showcasing Significant Advances in Cancer Care at 2022 ASCO Annual Meeting Prostate cancer...